Latest Breaking News On - Corporate communications investors - Page 9 : comparemela.com

Mesoblast Operational and Financial Highlights for Quarter Ended September 30, 2022

Mesoblast Operational and Financial Highlights for Quarter Ended September 30, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSteve dabkowskiPaul hughesMesoblast limited nasdaqCorporate communications investorsDrug administrationAustralian securities exchangeLicense applicationInvestigational new drugFast track designationExecutive directorsNon executive directorsQuarterly cash flow reportMesoblast limitedSteroid refractory acute graft versus hostBiol blood marrow

Mesoblast Operational and Financial Highlights for Quarter

Quarterly Activity Report.

United statesSteve dabkowskiPaul hughesMesoblast limited nasdaqCorporate communications investorsDrug administrationAustralian securities exchangeLicense applicationInvestigational new drugFast track designationExecutive directorsNon executive directorsQuarterly cash flow reportMesoblast limitedSteroid refractory acute graft versus hostBiol blood marrow

Mesoblast Reports Financial Results and Operational

At June 30, 2022, cash-on-hand was US$60.4 million with pro-forma US$105.5 million after raising gross proceeds of US$45 million via a private placement in.

United statesSilviu itescuPaul hughesVanderbilt university medical centerDrug administrationPharmaceuticals coResearch developmentAustralian securities exchangeMesoblast limited nasdaqCorporate communications investorsChief executiveBiologics license applicationComplete response letterUnited states foodKey opinion leaderContingent consideration

Mesoblast Corporate Update and Financial Results Webcast

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesPaul hughesCorporate communications investorsAustralian securities exchangeMesoblast limitedGlobe newswire

Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022

Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSilviu itescuPaul hughesVanderbilt university medical centerDrug administrationPharmaceuticals coResearch developmentAustralian securities exchangeMesoblast limited nasdaqCorporate communications investorsChief executiveBiologics license applicationComplete response letterUnited states foodKey opinion leaderDisease royalties